Bulletin
Investor Alert

Atara Biotherapeutics Inc.

NAS: ATRA

GO
/marketstate/country/us

After Hours

/zigman2/quotes/200374338/composite

$

13.37

Change

-0.04 -0.34%

Volume

Volume 8,402

Sep 23, 2020, 5:58 p.m.

Quotes are delayed by 20 min

/zigman2/quotes/200374338/composite

Today's close

$ 14.12

$ 13.42

Change

-0.71 -4.99%

Day low

Day high

$13.36

$14.33

Open
Open: 14.17

52 week low

52 week high

$4.52

$19.36

Open

Market cap

$1.05B

Average volume

848,422

P/E ratio

N/A

Rev. per Employee

N/A

EPS

-5.01

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/atra

MarketWatch News on ATRA

  1. Atara Biotherapeutics started at outperform at Evercore ISI

    6:45 a.m. June 30, 2020

    - Tomi Kilgore

  2. Beth Seidenberg

    10:49 a.m. April 10, 2020

    - Barron's Online

  3. Atara Biotherapeutics stock price target cut to $22 from $43 at J.P. Morgan

    7:47 a.m. Nov. 8, 2019

    - Tomi Kilgore

  4. Atara Biotherapeutics downgraded to neutral from overweight at J.P. Morgan

    7:47 a.m. Nov. 8, 2019

    - Tomi Kilgore

  5. Atara Biotherapeutics Stock Falls After Goldman Downgrade

    10:50 a.m. Sept. 27, 2019

    - Barron's Online

  6. A Cheap Biotech Is Testing a Novel Treatment for Multiple Sclerosis

    8:29 a.m. Sept. 13, 2019

    - Barron's Online

  7. Atara Biotherapeutics started at buy with $41 stock price target at Stifel Nicolaus

    7:30 a.m. May 23, 2019

    - Tomi Kilgore

  8. S&P 500 nails the breakout point (again) amid garden-variety pullback

    11:16 a.m. Sept. 26, 2018

    - Michael Ashbaugh

  9. Atara Biotherapeutics stock price target raised to $70 from $47 at Canaccord Genuity

    11:56 a.m. Jan. 19, 2018

    - Tomi Kilgore

  10. Celgene: Two Small-Cap Biotech Stocks It’s Selling

    2:24 p.m. Dec. 27, 2017

    - Barron's Online

  11. Morgan Stanley: Three Stocks It’s Buying Now

    3:21 p.m. Dec. 18, 2017

    - Barron's Online

  12. Atara Biotherapeutics shares rise on MS drug study results

    5:16 p.m. April 20, 2017

    - Wallace Witkowski

  13. Atara Biotherapeutics downgraded to sell from neutral at Goldman Sachs

    9:54 a.m. Sept. 15, 2016

    - Tomi Kilgore

  14. Atara Biotherapeutics stock price target cut to $16 from $23 at Goldman Sachs

    9:55 a.m. Sept. 15, 2016

    - Tomi Kilgore

Analyst Ratings

/news/nonmarketwatch/company/us/atra

Other News on ATRA

  1. Wall Street Analysts Are Bullish on Top Healthcare Picks

    6:45 a.m. Sept. 15, 2020

    - SmarterAnalyst

  2. Company News for Sep 14, 2020

    9:28 a.m. Sept. 14, 2020

    - Zacks.com

  3. Atara (ATRA) Looks Good: Stock Adds 5.1% in Session

    8:47 a.m. Sept. 14, 2020

    - Zacks.com

  4. Atara Bio lead candidate shows sustained benefit in MS patients

    9:12 a.m. Sept. 11, 2020

    - Seeking Alpha

  5. Wall Street Breakfast: The Week Ahead

    4:42 a.m. Sept. 6, 2020

    - Seeking Alpha

  6. Tracking Seth Klarman's Baupost Group Holdings - Q2 2020 Update

    8:00 a.m. Aug. 15, 2020

    - Seeking Alpha

  7. Genomic Medicine: Summer 2020 Update

    9:36 a.m. Aug. 13, 2020

    - Seeking Alpha

  8. 10-Q: ATARA BIOTHERAPEUTICS, INC.

    4:14 p.m. Aug. 5, 2020

    - Edgar Online - (EDG = 10Q, 10K)

  9. Assessing An Investment In Atara Biotherapeutics

    11:59 a.m. Aug. 4, 2020

    - Seeking Alpha

  10. IPO Update: AlloVir Proposes Terms For $251 Million IPO

    12:18 p.m. July 26, 2020

    - Seeking Alpha

  11. Loading more headlines...
/news/pressrelease/company/us/atra

Press Releases on ATRA

  1. Loading more headlines...

Rates »

Link to MarketWatch's Slice.